Marker Therapeutics is trading at $1.17, up 5.41% in pre-market after closing at $1.11 on August 13, 2026; no clear company-specific announcement explaining the move was found.
- The investor-relations page lists its latest release as March 18, 2026, with no August 13–14 announcement shown.
- Broader futures were only modestly mixed, so the gain cannot be confidently attributed to market-wide sentiment.